Skip to main content
Clinical Trials/NCT05438537
NCT05438537
Recruiting
Not Applicable

A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)

Chinese University of Hong Kong1 site in 1 country300 target enrollmentNovember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Upper Tract Urothelial Cancer
Sponsor
Chinese University of Hong Kong
Enrollment
300
Locations
1
Primary Endpoint
Long-term survival
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

There are many controversies and limitations in the management of Upper Tract Urothelial cancer. A prospective registry is set up for patients in our hospital, aim to have a comprehensive prospective assessment of the physical and biological effects of Upper Tract Urothelial cancer in our patients

Detailed Description

Although Upper Tract Urothelial Carcinoma (UTUC) is relatively uncommon, the incidence rate is increasing. There are many controversies and limitations in the management of Upper Tract Urothelial cancer. In this study, investigators would like to establish a local registry for upper tract urothelial cancer to facilitate the collection of clinical information and outcomes of upper tract urothelial cancer management, and to collect blood, urine and tumour tissue samples to investigate for new diagnostic and therapeutic agents. Hopefully, our registry can provide information regarding the epidemiology, natural history, and treatment outcomes of upper tract urothelial cancer in Hong Kong.

Registry
clinicaltrials.gov
Start Date
November 1, 2021
End Date
December 30, 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jeremy Yuen Chun TEOH

Assistant Professor

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Male patients \> 18 years old
  • Patients who has presence of UTUC and pending for surgery
  • Patients who has history of UTUC with any intervention performed

Exclusion Criteria

  • Patients fail to provide informed consent

Outcomes

Primary Outcomes

Long-term survival

Time Frame: 10 years

Long-term survival

Secondary Outcomes

  • Progression rate of UTUC(10 years)
  • Complications(10 years)
  • Recurrence rate of UTUC(10 years)

Study Sites (1)

Loading locations...

Similar Trials